Sustainability in action

The pharmaceutical industry's journey towards net zero emissions has transformed sustainability from a compliance requirement to a strategic imperative. With the majority of emissions falling into Scope 3, pharmaceutical companies need to look beyond their own operations to their entire supply chain to make a meaningful impact.

As part of the “elmplastic customer advantage series” on LinkedIn, this white paper explores the critical role of comprehensive sustainability in the pharmaceutical sector. It explores how companies can navigate the complex landscape of emissions reduction, identifies key areas where meaningful progress can be made, and offers practical insights into implementing effective ESG strategies across multiple operational dimensions.

Based in the Eifel region of Germany, elmplastic is a specialist manufacturer of pharmaceutical packaging for primary packaging and dosing devices that has integrated comprehensive ESG practices into its operations. We combine modern energy-efficient production facilities, AI-optimized waste management systems and robust social responsibility initiatives to deliver sustainable packaging solutions.

Download the whitepaper here to learn more about sustainability strategies and ESG implementation approaches in the pharmaceutical industry.

Follow elmplastic on LinkedIn to stay updated with our latest insights and company developments.